Page 1 | Search Results | Blood | American Society of Hematology

1-9 of 9

Sort by

Sort Order Select

Journal Articles

CLAG±M (cladribine, cytarabine, granulocyte colony stimulating factor ± mitoxantrone) Results in High Response Rates in Older Patients with Secondary and Relapsed/Refractory Acute Myeloid Leukemia - a Single Institute Experience

Monica Reddy Muppidi, MD, Craig W. Freyer, PharmD, Laurie Ann Ford, Evelena P Ontiveros, MD PhD, James E. Thompson, MD, Elizabeth A. Griffiths, MD, Eunice S. Wang, MD

Blood (2015) 126 (23): 1341.

https://doi.org/10.1182/blood.V126.23.1341.1341

Published: 2015

Journal Articles

Induction of Cancer Testis Antigen Expression in Circulating Acute Myeloid Leukemia Blasts Following Hypomethylating Agent Monotherapy

Pragya Srivastava, PhD, Benjamin E. Paluch, Junko Matsuzaki, PhD, Smitha R. James, Golda Collmat-Lai, Nadja Blagitko-Dorfs, Laurie Ann Ford, Rafeh Naqash, MD, Michael Luebbert, MD, Adam R. Karpf, PhD, Michael J. Nemeth, PhD, Elizabeth A. Griffiths, MD

Blood (2015) 126 (23): 2537.

https://doi.org/10.1182/blood.V126.23.2537.2537

Published: 2015

Journal Articles

Diverse Roles of Hepatocyte Growth Factor (HGF) in Normal Karyotype Acute Myeloid Leukemia (AML).

Ian McInnis, Theresa Hahn, PhD, Anasitasia Ioane, Ashleigh Lamson, Deepika Lal, Laurie Ann Ford, Sheila NJ Sait, Petr Starostik, MD, George Deeb, MD, Meir Wetzler, MD, Terry Mashtare, Jr., Eunice S. Wang, M.D.

Blood (2009) 114 (22): 3107.

https://doi.org/10.1182/blood.V114.22.3107.3107

Published: 2009

Journal Articles

Myeloid Blastic Transformation of Myeloproliferative Neoplasms – A Review of 113 Cases.

Syed Noor, MD, Wei Tan, PhD, Gregory Wilding, PhD, Laurie Ann Ford, Maurice Barcos, MD, PhD, Sheila N.J. Sait, PhD, AnneMarie W. Block, PhD, James E. Thompson, MD, Eunice S. Wang, MD, Meir Wetzler, MD

Blood (2009) 114 (22): 3113.

https://doi.org/10.1182/blood.V114.22.3113.3113

Published: 2009

Journal Articles

CD33-Negative Acute Myeloid Leukemia (AML) Has Similar Characteristics to CD33-Positive Disease.

Cecilia Y. Arana Yi, MD, Wei Tan, Ph.D., Gregory Wilding, Ph.D., Laurie Ann Ford, Sheila N.J. Sait, PhD, AnneMarie W. Block, PhD, George Deeb, MD, Paul K. Wallace, MS, PhD, Petr Starostik, MD, James E. Thompson, MD, Eunice S. Wang, MD, Meir Wetzler, MD

Blood (2009) 114 (22): 4129.

https://doi.org/10.1182/blood.V114.22.4129.4129

Published: 2009

Journal Articles

Smoking Adversely Affects Survival in Acute Myeloid Leukemia Patients.

Ramya Varadarajan, MD, Andrea Licht, MS, Andrew J. Hyland, PhD, Laurie Ann Ford, Maurice Barcos, MD, PhD, Sheila N.J. Sait, PhD, AnneMarie W. Block, PhD, Maria R. Baer, MD, James E. Thompson, MD, Eunice S. Wang, MD, Meir Wetzler, MD

Blood (2009) 114 (22): 979.

https://doi.org/10.1182/blood.V114.22.979.979

Published: 2009

Journal Articles

XPD DNA Nucleotide Excision Repair (NER) Gene Polymorphisms Associated with DNA Repair Deficiency May Predict Better Treatment Outcomes in Secondary Acute Myeloid Leukemia (AML).

Nataliya Kuptsova-Clarkson, PhD, Christine Ambrosone, PhD, Joli Weiss, PhD, Maria R. Baer, MD, Lara Sucheston, PhD, Gary Zirpoli, PhD, Kenneth Kopecky, PhD, Laurie Ann Ford, Javier Blanco, PhD, Meir Wetzler, MD, Kirsten Moysich, PhD

Blood (2009) 114 (22): 168.

https://doi.org/10.1182/blood.V114.22.168.168

Published: 2009

Journal Articles

Expression of Vascular Endothelial Growth Factor Receptors VEGFR-1 and VEGFR-2 Are Prognostic Factors in Normal Karyotype Acute Myeloid Leukemia (NK-AML)

Kellie M. Demock, Joseph Marinaro, Amanda Sobczyk, Laurie Ann Ford, Meir Wetzler, MD, George Deeb, MD, Lili Tian, Eunice S. Wang, MD

Blood (2008) 112 (11): 2552.

https://doi.org/10.1182/blood.V112.11.2552.2552

Published: 2008

Journal Articles

Hypoxia-Inducible Factor-1 Alpha (HIF-1α) and HIF-2α Are Independent Prognostic Factors for Normal Karyotype Acute Myeloid Leukemia (NK AML)

Kellie M. Demock, Joseph Marinaro, Ian McInnis, Laurie Ann Ford, Meir Wetzler, MD, Lili Tian, George Deeb, MD, Eunice S. Wang, MD

Blood (2008) 112 (11): 2553.

https://doi.org/10.1182/blood.V112.11.2553.2553

Published: 2008

NARROW

CLAG±M (cladribine, cytarabine, granulocyte colony stimulating factor ± mitoxantrone) Results in High Response Rates in Older Patients with Secondary and Relapsed/Refractory Acute Myeloid Leukemia - a Single Institute Experience

Induction of Cancer Testis Antigen Expression in Circulating Acute Myeloid Leukemia Blasts Following Hypomethylating Agent Monotherapy

Diverse Roles of Hepatocyte Growth Factor (HGF) in Normal Karyotype Acute Myeloid Leukemia (AML).

Myeloid Blastic Transformation of Myeloproliferative Neoplasms – A Review of 113 Cases.

CD33-Negative Acute Myeloid Leukemia (AML) Has Similar Characteristics to CD33-Positive Disease.

Smoking Adversely Affects Survival in Acute Myeloid Leukemia Patients.

XPD DNA Nucleotide Excision Repair (NER) Gene Polymorphisms Associated with DNA Repair Deficiency May Predict Better Treatment Outcomes in Secondary Acute Myeloid Leukemia (AML).

Expression of Vascular Endothelial Growth Factor Receptors VEGFR-1 and VEGFR-2 Are Prognostic Factors in Normal Karyotype Acute Myeloid Leukemia (NK-AML)

Hypoxia-Inducible Factor-1 Alpha (HIF-1α) and HIF-2α Are Independent Prognostic Factors for Normal Karyotype Acute Myeloid Leukemia (NK AML)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only